Comparison of treatment plans for hypofractionated high-dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms.

Jörg TamihardjaGary RazinskasFlorian ExnerAnne RichterPatrick KesslerStefan WeickJohannes KraftFrederick MantelMichael FlentjeBülent Polat

Published in: Journal of applied clinical medical physics (2021)

Hypofractionated high-dose prostate cancer SIB VMAT on the Halcyon system is feasible with comparable plan quality in reference to a standard C-arm Elekta Synergy linac.

Keyphrases

high dose
prostate cancer
radiation therapy
radical prostatectomy
low dose
stem cell transplantation
early stage
locally advanced
radiation induced
brain metastases
squamous cell carcinoma
health insurance
small cell lung cancer
quality improvement
combination therapy
smoking cessation